SCHEMBL233379

SCHEMBL233379

CC#CCCC#CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11573275 0.82
SCHEMBL8588368 0.82 RAB9A (0.38)
SCHEMBL5178799 0.82
SCHEMBL1417773 0.82
SCHEMBL19999793 0.82
SCHEMBL1725965 0.82
SCHEMBL2698476 0.82
SCHEMBL2261149 0.82
SCHEMBL1897706 0.79
SCHEMBL3618326 0.79 RAB9A (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570798-B2 Polyether compound and gas separation membrane ZEON CORPORATION (JP) 2026-03-10 US disclosed
US-12064239-B2 Device and methods for detection and monitoring of tuberculosis TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2024-08-20 US disclosed
US-12037329-B2 SphK inhibitors and methods of making and using same WASHINGTON UNIVERSITY (US) 2024-07-16 US disclosed
US-20240226342-A1 REACTIVE OXYGEN SPECIES IMAGING AGENTS WASHINGTON UNIVERSITY (US) 2024-07-11 US disclosed
CN-113677364-B Pharmaceutical compositions comprising anti-191P 4D12 antibody drug conjugates and methods of use thereof 艾更斯司股份有限公司 2024-07-05 CN disclosed
US-12016842-B2 Methods of using anti-CD79b immunoconjugates GENENTECH, INC. (US) 2024-06-25 US disclosed
EP-4380978-A1 METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA Genentech, Inc. (US) 2024-06-12 EP disclosed
EP-4378482-A2 DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES Seagen Inc. (US) 2024-06-05 EP disclosed
US-20240179825-A1 SYSTEMS AND METHODS FOR NONEQUILIBRIUM PLASMAS WASHINGTON UNIVERSITY 2024-05-30 US disclosed
US-20240167096-A1 PLASMA CELL-FREE RNA AND METHODS OF USE THEREOF AS NON-INVASIVE BIOMARKERS FOR ALZHEIMER'S DISEASE WASHINGTON UNIVERSITY (US) 2024-05-23 US disclosed
US-20040044003-A1 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. 2004-03-04 US disclosed
US-20040033253-A1 Acyl opioid antagonists PURDUE PHARMA L.P. 2004-02-19 US disclosed
WO-2004010957-A2 DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE SEATTLE GENETICS, INC. (US) 2004-02-05 WO disclosed
WO-2004004774-A2 COMPOSITIONS COMPRISING PANTHETINE FOR THE TREATMENT OF DYSLIPIDEMIA ESPERION THERAPEUTICS, INC. (US) 2004-01-15 WO disclosed
US-20040006091-A1 Therapeutic agents useful for treating or preventing pain PURDUE PHARMA L.P. 2004-01-08 US disclosed
WO-2004002983-A2 THERAPEUTIC PIPERAZINE DERIVATIVES USEFUL FOR TREATING PAIN EURO-CELTIQUE, S.A. (LU) 2004-01-08 WO disclosed
WO-2003074520-A1 THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN EURO-CELTIQUE, S.A. (LU) 2003-09-12 WO disclosed
WO-2003066595-A2 2 - PIPERAZINE - PYRIDINES USEFUL FOR TREATING PAIN EURO-CELTIQUE S.A. (LU) 2003-08-14 WO disclosed
EP-0598134-A1 PROCESS FOR PRODUCING POLYOLEFIN IDEMITSU KOSAN COMPANY LIMITED (JP) 1994-05-25 EP disclosed
US-4299758-A REACTING HEXACHLOROCYCLOPENTADIENE WITH A 1,5-HEXADIYNE AT ELEVATED TEMPERATURE NATIONAL DISTILLERS AND CHEMICAL CORP. (US) 1981-11-10 US disclosed